Related Experiment Video
Updated: Jun 1, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Resolution of symptoms in nms : a case report
A Das1, R Gandhibabu, P J Alexander
1Arunava Das, M.D., D.P.M., Assistant Professor, Department of Psychiatry, Kasturba Medical College, Manipal.
Indian Journal of Psychiatry
|May 18, 2011
Summary
Neuroleptic Malignant Syndrome (NMS) presents with key symptoms but shows variability. This case highlights how co-existing conditions can complicate NMS diagnosis and management.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Neuroleptic Malignant Syndrome (NMS) is a rare but serious adverse reaction to antipsychotic medications.
- NMS is characterized by hyperthermia, muscle rigidity, altered mental status, and autonomic instability.
- Significant heterogeneity exists in NMS presentation, onset, and resolution, often complicated by comorbid conditions.
Purpose of the Study:
- To report a unique case presentation of Neuroleptic Malignant Syndrome.
- To illustrate how comorbid physical conditions can obscure the typical NMS picture.
- To contribute to understanding the variability in NMS manifestations.
Main Methods:
- Case report detailing a patient with NMS.
- Review of clinical presentation, laboratory findings, and treatment response.
- Analysis of the impact of comorbid conditions on NMS diagnosis.
Main Results:
- The reported case exhibited atypical features of NMS.
- Comorbid conditions presented diagnostic challenges.
- The patient's response to treatment was influenced by the complex clinical picture.
Conclusions:
- Neuroleptic Malignant Syndrome can present heterogeneously, especially with comorbid illnesses.
- Accurate diagnosis requires careful consideration of all clinical factors.
- Further case reports are valuable for understanding NMS variability.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...